The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Voriconazole Concentrations in the Cerebrospinal Fluid and Brain Tissue of Guinea Pigs and Immunocompromised Patients
Abstract
We characterized voriconazole concentrations in the cerebrospinal fluid (CSF) of immunocompetent guinea pigs and patients with invasive fungal infections. In animals, after receipt of oral doses of 4 or 10 mg/kg every 8 h, the mean ratios of CSF to plasma total and free drug concentration were 0.68 and 1.3, respectively. In humans, 1-10 h after receipt of voriconazole, the CSF concentrations ranged from 0.08 to 3.93 microg/mL, and the ratio of CSF to plasma concentration ranged from 0.22 to 1.0 (median, 0.46).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
Denning, D. W., Ribaud, P., Milpied, N., Caillot, D., Herbrecht, R., Thiel, E., Haas, A., Ruhnke, M., & Lode, H. (2002) · Clinical Infectious Diseases · doi:10.1086/324620 · Cited by 844
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 820
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Oral Azole Drugs as Systemic Antifungal Therapy
Wood, A. J. J., Como, J. A., & Dismukes, W. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300407 · Cited by 596
Transporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
WALSH, T. J., LUTSAR, I., DRISCOLL, T., DUPONT, B., RODEN, M., GHAHRAMANI, P., HODGES, M., GROLL, A. H., & PERFECT, J. R. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200203000-00015 · Cited by 431
Self-citationEspinel-Ingroff, A., Boyle, K., & Sheehan, D. J. (2001) · Mycopathologia · doi:10.1023/a:1010954803886 · Cited by 251
Antibiotic Pharmacodynamics in Cerebrospinal Fluid
Lutsar, I., McCracken, Jr., & Friedland, I. R. (1998) · Clinical Infectious Diseases · doi:10.1086/515003 · Cited by 242
Self-citationLyman, C. A., & Walsh, T. J. (1992) · Drugs · doi:10.2165/00003495-199244010-00002 · Cited by 233
Nesky, M. A., McDougal, E. C., & Peacock, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/314042 · Cited by 214
Arndt, C. A. S., Walsh, T. J., McCully, C. L., Balis, F. M., Pizzo, P. A., & Poplack, D. G. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/157.1.178 · Cited by 169
Schwartz, S., Milatovic, D., & Thiel, E. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.972911.x · Cited by 164
Aspergillus Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management
Verweij, P. E., Brinkman, K., Kremer, H. P. H., Kullberg, B.-J., & Meis, J. F. G. M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.1186-1189.1999 · Cited by 159
Voriconazole -- better chances for patients with invasive mycoses.
Ghannoum, M. A., & Kuhn, D. M. (2002) · PubMed · Cited by 150
Gottfreðsson, M., & Perfect, J. R. (2000) · Seminars in Neurology · doi:10.1055/s-2000-9394 · Cited by 136
PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIBIOTICS IN MENINGITIS
Andes, D. R., & Craig, W. A. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70096-9 · Cited by 116
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits
Perfect, J. R., & Durack, D. T. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.1.81 · Cited by 107
Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System Infections
Nau, R., rgel, F. S., & Prange, H. W. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835030-00005 · Cited by 98
Meningitis Caused by Pseudallescheria boydii Treated with Voriconazole
Poza, G., Montoya, J. G., Redondo, C., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313817 · Cited by 82
British Journal of Haematology
British Society for Haematology, & European Hematology Association (2010) · British Journal of Haematology · doi:10.1111/(issn)1365-2141 · Cited by 73
Treatment of Cerebral Aspergillosis with Itraconazole: Do High Doses Improve the Prognosis?
Sanchez, C., Mauri, E., Dalman, D., Quintana, S., Aparicio, A., & Garau, J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1485 · Cited by 61
Jafari, H. S., Sáez‐Llorens, X., Severien, C., Parras, F., Friedland, I. R., Rinderknecht, S. B., Ehrett, S., Olsen, K. D., Abramowsky, C. R., & McCracken, G. H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.83 · Cited by 28
Sj, P., & Jackson, G. H. (1997) · PubMed · doi:10.25405/ncl.34582476 · Cited by 7
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Nau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,026
Chapman, S. W., Dismukes, W. E., Proia, L. A., Bradsher, R. W., Pappas, P. G., Threlkeld, M. G., & Kauffman, C. A. (2008) · Clinical Infectious Diseases · doi:10.1086/588300 · Cited by 759
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Brüggemann, R. J. M., Alffenaar, J. C., Blijlevens, N. M. A., Billaud, E. M., Kosterink, J. G. W., Verweij, P. E., & Burger, D. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598327 · Cited by 457
Metadata
- Authors
- Lutsar, I., Roffey, S., & Troke, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-01
- Volume
- 37
- Issue
- 5
- Pages
- 728-732
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2158019501
- Cited by
- 262
- References
- 24
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.